Buying Juno could help Celgene diversify its portfolio as its top-selling drug approaches patent expiration. » Read More
By: Dan Mangan
Abortion rights and LGBT advocates are pushing back against a bid to shield health workers who refuse to perform services on moral grounds. » Read More
By: Reed Abelson and Katie Thomas
Several major hospital systems plan to form a drug company that will provide generic drugs in short supply to the hospitals, the New York Times reports. » Read More
Trump said he gets more exercise than people think, but he was open to changing his diet, starting with smaller portion meal sizes. » Read More
GlaxoSmithKline said its CEO Andrew Witty would retire in 12 months, prompting Britain's biggest drugmaker to start a formal search for his successor.
McKesson is cutting 1,600 jobs, or about 4 percent of its workforce, to slash costs after the company lost some key customers, Bloomberg reported.
Creditors of Valeant Pharmaceuticals are beginning to demand new terms that could further pressure the drugmaker's business model, sources said.
The Obama administration is accused of illegally giving insurers reimbursement to cut Obamacare customer out-of-pocket costs.
Almost 20 percent of rural counties have seen increases in the rate of premature deaths in the past decade.
Estimates say Trump's proposal to repeal Obamacare and make other changes could cost nearly $500 billion and lead to 21 million more uninsured people.
For the first time ever, the NFL has acknowledged that there is a link between football and brain damage.
Andrew Left of Citron Research explains why Mallinckrodt is worse than Valeant. Mark Trudeau, Mallinckrodt CEO, responds.
Presidential candidates may talk about combating high drug prices, but Express Scripts' Dr. Steve Miller says it takes more than talk to make it work.
Wall Street investor Bill Ackman says he is still confident in Valeant and he plans to be more proactive in his dealings with it.
Blackstone's president and a New School economist say it's time to take this looming retirement crisis seriously.
"This is a way to get rid of a terrible, terrible drug, oxycodone," CNBC's Jim Cramer says.
The pharmaceutical industry has donated more to Clinton's campaign than to any other candidate. This despite her harsh words for the industry.
There have already been more than 30 health data breaches involving more than 900,000 patient records in 2016.
Toshiba has granted Canon exclusive negotiating rights for its medical equipment unit after a hotly contested auction.
Drug spending increased by 12.6 percent in 2014, and will average a projected 7.3 percent annually through 2018.
The savings offered by retail health clinics were outweighed by the overall spending increase resulting from increased use.
The infectious disease advisory group will assist Team USA in the mitigation, assessment and management of potential illnesses.
The 26-story facility would service Americans who travel to Mexico for less-expensive medical care.
Researchers have found a new way to identify immune cells capable of detecting tumors, The Financial Times reports.
Get the best of CNBC in your inbox